Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-18-013757)

Filing Details

Accession Number:: 0001179110-18-013757
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-12-12 16:57:44
Reporting Period:: 2018-12-10

Accepted Time:: 2018-12-12 16:57:44
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1061027	Sunesis Pharmaceuticals Inc	SNSS	Pharmaceutical Preparations (2834)	943295878

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1724190	P. William Quinn	Sunesis Pharmaceuticals, Inc. 395 Oyster Point Boulevard, Ste. 400 South San Francisco CA 94080	Cfo,Sr.v.p. Finance, Corp.dev.	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-12-10	40,000	$0.47	52,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Includes 6,000 shares acquired under the Issuer's stock purchase plan on May 31, 2018 and 6,000 shares acquired under the Issuer's stock purchase plan on November 30, 2018.